Prostate Cancer Japan Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • January 2015
  • 74 pages

Executive Summary •The estimated market size for lung cancer therapeutics in 2014 was $ x billion. •There is increasing competition in this market, especially amongst the large pharmaceutical (pharma) participants such as Merck, AstraZeneca, Eli Lilly, and Bristol-Myers Squibb (BMS), which are set ...

Industries: Therapy | Countries: China, Japan, United States

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 109 pages

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015', provides an overview of the Chemotherapy Induced Neutropenia's therapeutic pipeline. This report provides comprehensive information on the therapeutic ...

Industries: Therapy | Countries: United States, World, Japan

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

D. Western Therapeutics Institute, Inc. (4576) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary D. Western Therapeutics Institute, Inc. (DWTI) is a pharmaceutical company. The company discovers and develops new drugs. Its products include K-134, K-115, HMN-214, and HMN-1129. DWTI's K-134 is a clinical candidate for anti-platelet drug which is used for the treatment of arteriosclerosis obliterans. ...

Industries: Therapy | Countries: Japan

World Radiation Therapy Equipment Industry

World Radiation Therapy Equipment Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • January 2015
  • 360 pages

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, ...

Industries: Therapy | Countries: World, United States, Japan, Europe, Canada

Epilepsy Therapeutics Market in the APAC Region 2015-2019

Epilepsy Therapeutics Market in the APAC Region 2015-2019

  • $ 2 500
  • Industry report
  • by Infiniti Research Limited
  • December 2014
  • 86 pages

About Epilepsy Therapeutics Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying ...

Industries: Therapy | Countries: China, Australia, Japan, India, World, Asia

Respiratory Therapy News DECEMBER 2014

Respiratory Therapy News DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 8 pages

Industry Brief - BeyondSpring To Initiate Plinabulin Phase III Trial In NSCLC Industry Brief - FDA Grants Fast Track Designation To Novavax' RSV F Vaccine Industry Brief - FDA Grants QIDP Designation To Bayer's Amikacin Inhale/Ciprofloxacin DPI Industry Brief - CHMP Issues Positive Opinion For BI's Nintedani ...

Industries: Therapy | Countries: Canada, Spain, Italy, Germany, Japan, Europe, United Kingdom, World

Global Proton Therapy Market and Centers Analysis

Global Proton Therapy Market and Centers Analysis

  • $ 1 000
  • Industry report
  • by Igate Research
  • December 2014
  • 126 pages

Proton beam therapy is going through an interesting period right now as the unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. Proton therapy is a type of particle therapy which is used to treat cancer patients by means of ...

Industries: Therapy | Countries: United States, Japan, World, South Korea

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 105 pages

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014', provides an overview of the Chemotherapy Induced Neutropenia's therapeutic pipeline. This report provides comprehensive information on the therapeutic ...

Industries: Therapy | Countries: World, Japan

 Nasal Congestion-API Insights, 2014

Nasal Congestion-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Therapy | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Canada, Japan

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies

  • $ 4 995
  • Industry report
  • by GBI Research
  • October 2014
  • 98 pages

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies Summary GBI Research, the leading business intelligence provider, has released its latest research, "Colorectal Cancer Therapeutics in Asia-Pacific Markets ...

Industries: Therapy | Countries: World, Australia, India, Japan, China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.